Literature DB >> 21308203

[Human and animal fascioliasis in Peru: impact in the economy of endemic zones].

José R Espinoza1, Angélica Terashima, Patricia Herrera-Velit, Luis A Marcos.   

Abstract

Fasciola hepatica is the causative agent of fasciolosis in Peru; the disease is an important public health problem by the high prevalence of the human infection affecting mainly children and a major veterinary problem by the high rates of infected livestock. The human disease is endemic in the Sierra and the Coast but sporadic in the Amazonia, and reported in 18 Departments, while the animal infection in 21 of 24 Departments of Peru. Transmission occurs in Andean rural populations engaged in agriculture, but recently an increasing number of people became infected in the cities. The epidemiological situation in Peru includes i) Departments with non-autochtonous cases, where infection occurs by consumption of contaminated vegetables brought from endemic areas or infection is acquired by visit to endemic areas; ii) Departments with hypoendemic and mesoendemic villages, where transmission occurs by ingest of contaminated vegetables and prevalence ≤10%; and iii) Departments with hyper-endemic villages with human prevalence >10 %, with an intense transmission by consumption of contaminated vegetables. The disease affects bovine, sheep, goat, swine, equine, South American camelids, rabbits and guinea pigs. The negative impact of fasciolosis in the livestock economy is not lesser than US$ 50 million per year, estimation based on the prevalence and the number of condemned livers in the abattoirs. It is difficult to estimate the economic impact of this infection in the human health due to its status of neglected disease, but fasciolosis is hyper-endemic in the poorest Andean areas of Peru where the situation has to be recognized as a public health emergency.

Entities:  

Mesh:

Year:  2010        PMID: 21308203     DOI: 10.1590/s1726-46342010000400018

Source DB:  PubMed          Journal:  Rev Peru Med Exp Salud Publica        ISSN: 1726-4634


  16 in total

1.  Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheep.

Authors:  Luis A Gomez-Puerta; Cesar Gavidia; Maria T Lopez-Urbina; Hector H Garcia; Armando E Gonzalez
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Development of two antibody detection enzyme-linked immunosorbent assays for serodiagnosis of human chronic fascioliasis.

Authors:  Kimberly Cabán-Hernández; José F Gaudier; Caleb Ruiz-Jiménez; Ana M Espino
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

3.  Microsatellite analysis of Fasciola spp. in Egypt.

Authors:  Yasser Dar; Said Amer; Bertrand Courtioux; Gilles Dreyfuss
Journal:  Parasitol Res       Date:  2011-07-09       Impact factor: 2.289

4.  Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis.

Authors:  Olgary Figueroa-Santiago; Bonnibel Delgado; Ana M Espino
Journal:  Diagn Microbiol Infect Dis       Date:  2011-07       Impact factor: 2.803

5.  Activity of OZ78 analogues against Fasciola hepatica and Echinostoma caproni.

Authors:  Carla Kirchhofer; Mireille Vargas; Olivier Braissant; Yuxiang Dong; Xiaofang Wang; Jonathan L Vennerstrom; Jennifer Keiser
Journal:  Acta Trop       Date:  2011-02-21       Impact factor: 3.112

6.  First Report of Human Fascioliasis in an Endemic Region of Bovine Fascioliasis in Caldas-Colombia.

Authors:  Jorge Enrique Perez-C; Etna Julieth Giraldo-Pinzon; Sandra Aguilar-Marín
Journal:  Vector Borne Zoonotic Dis       Date:  2016-04-05       Impact factor: 2.133

7.  Spread of the fascioliasis endemic area assessed by seasonal follow-up of rDNA ITS-2 sequenced lymnaeid populations in Cajamarca, Peru.

Authors:  J N Bardales-Valdivia; M D Bargues; C Hoban-Vergara; C Bardales-Bardales; C Goicochea-Portal; H Bazán-Zurita; J Del Valle-Mendoza; P Ortiz; S Mas-Coma
Journal:  One Health       Date:  2021-05-11

8.  Comparison of Liver Condemnation and Bile Microscopy As Tools to Estimate Fasciola hepatica Prevalence and Burden in the Anta Province of Cusco in Peru.

Authors:  Maria Alejandra Caravedo; A Clinton White; Maria Luisa Morales; Martha Lopez; Melinda Barbara Tanabe; Benicia Baca-Turpo; Eulogia Arque; Daniela Madrid; Prithvi Vallabh; Ruben Bascope; Miguel Mauricio Cabada
Journal:  Vector Borne Zoonotic Dis       Date:  2021-06-14       Impact factor: 2.523

9.  Molecular characterization of cryptic and sympatric lymnaeid species from the Galba/Fossaria group in Mendoza Province, Northern Patagonia, Argentina.

Authors:  Claire J Standley; Lucila Prepelitchi; Silvia M Pietrokovsky; Laura Issia; J Russell Stothard; Cristina Wisnivesky-Colli
Journal:  Parasit Vectors       Date:  2013-10-23       Impact factor: 3.876

10.  Tegument Glycoproteins and Cathepsins of Newly Excysted Juvenile Fasciola hepatica Carry Mannosidic and Paucimannosidic N-glycans.

Authors:  Andres Garcia-Campos; Alessandra Ravidà; D Linh Nguyen; Krystyna Cwiklinski; John P Dalton; Cornelis H Hokke; Sandra O'Neill; Grace Mulcahy
Journal:  PLoS Negl Trop Dis       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.